- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03233906
The Effects of Chia on Overweight/Obese Women
May 8, 2018 updated by: Desiree Vera, California State Polytechnic University, Pomona
Effects of Chia Seed Consumption on Body Composition, Blood Pressure, Blood Glucose, Satiety, Diet Displacement, Joint Pain, Mood and Serotonin Levels in Young, Healthy, Overweight/Obese Females
The purpose of the study is to examine the effect of chia seed consumption on body composition, blood pressure, blood glucose, satiety, mood, joint pain, and dietary displacement in overweight and obese females (18-45years).
It is hypothesized that consuming chia seeds will bring about a positive change in body composition (lower % body fat), satiety, mood, joint pain, and blood pressure, lower blood glucose levels, increased fiber and improved nutrient intake, in overweight/ obese females.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Specific Objectives: 1. Determine if chia seed diet addition of 10% of Kcals (CHIA) positively changes body composition in young, healthy, overweight/obese people (Tanita scale).
A) Determine if CHIA will decrease blood pressure (monitor).
2. Determine if CHIA will decrease blood glucose (draw) 3. Determine if CHIA increases satiety and improves diet (recordings).
4. Determine if CHIA will decrease joint pain (questionnaire).
5. Determine if CHIA will increase positive mood changes (questionnaires) and increase blood serotonin levels (draw).
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Pomona, California, United States, 91766
- California State Polytechnic University, Pomona
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- are a female.
- are between the ages of 18 and 45.
- are not averse to consuming chia seeds on a regular basis (at least six weeks).
- have not taken any medication for any chronic disease (heart, diabetes, cancer) for twelve weeks.
- have not taken any steroid or hormone medication in the last eight weeks, excluding birth control pills...
- do not consume excess amounts of nuts and seeds. - do not consume alcohol on a regular basis.
- are not currently on a diet plan.
- are not pregnant or plan to become pregnant.
Exclusion Criteria:
- are a child, teenager, woman, or male younger than 18 or older than 45.
- eat large quantities of chia seeds on a regular basis.
- are taking any steroid or hormone medication (other than birth control pills). - are taking laxatives or fiber containing supplements on a regular basis.
- are pregnant or become pregnant.
- are currently on a diet plan.
- have a known allergy to seeds.
- consume excess amounts of seeds or nuts.
- consume alcohol on a regular basis.
- have a pacemaker or metal pins or plates in the body.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Chia Seeds
10% of a participants total kcal estimated needs given in chia seeds everyday for 8 weeks.
|
Chia seed added-10% of kcals and a no-chia control diet.
10% will be calculated using the following formula: Harris-Benedict equation multiplied by the activity factor of 1.2, 1.375, and 1.55 depending on each participant's activity level based on the information provided on the initial screening form.
|
|
No Intervention: Control
Habitual diet with avoidance of high fiber and high omega-3 fatty acid foods.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fasting plasma glucose
Time Frame: baseline
|
12-hour fasting plasma glucose levels will be assessed using a glucometer
|
baseline
|
|
Waist Circumference
Time Frame: baseline
|
waist circumference will be measured for each participant
|
baseline
|
|
Caloric intake
Time Frame: baseline
|
9, 3-day diet journals will be collected using a paper method
|
baseline
|
|
Serotonin
Time Frame: baseline
|
Urine serotonin levels will be assessed
|
baseline
|
|
Body Weight
Time Frame: Baseline
|
Tanita scale
|
Baseline
|
|
Body Mass Index
Time Frame: Baseline
|
Tanita sclae
|
Baseline
|
|
Body Fat Percentage
Time Frame: Baseline
|
Tanita scale
|
Baseline
|
|
Fasting plasma glucose
Time Frame: week 4
|
2-hour fasting plasma glucose levels will be assessed using a glucometer
|
week 4
|
|
Fasting plasma glucose
Time Frame: week 8
|
2-hour fasting plasma glucose levels will be assessed using a glucometer
|
week 8
|
|
Waist Circumference
Time Frame: week 4
|
waist circumference will be measured for each participant
|
week 4
|
|
Waist Circumference
Time Frame: week 8
|
waist will be measured for each participant
|
week 8
|
|
Caloric intake
Time Frame: week 4
|
9, 3-day diet journals will be collected using a paper method
|
week 4
|
|
Caloric intake
Time Frame: week 8
|
9, 3-day diet journals will be collected using a paper method
|
week 8
|
|
Serotonin
Time Frame: week 4
|
Urine serotonin levels will be assessed
|
week 4
|
|
Serotonin
Time Frame: week 8
|
Urine serotonin levels will be assessed
|
week 8
|
|
Body Weight
Time Frame: week 4
|
tanita scale
|
week 4
|
|
Body weight
Time Frame: week 8
|
tanita scale
|
week 8
|
|
Body mass index
Time Frame: week 4
|
tanita scale
|
week 4
|
|
body mass index
Time Frame: week 8
|
tanita scale
|
week 8
|
|
Body fat percentage
Time Frame: week 4
|
tanita scale
|
week 4
|
|
Body fat percentage
Time Frame: week 8
|
tanita scale
|
week 8
|
|
Hip Circumference
Time Frame: Baseline
|
Hip Circumference will be measured for each participant
|
Baseline
|
|
Hip Circumference
Time Frame: week 4
|
Hip Circumference will be measured for each participant
|
week 4
|
|
Hip Circumference
Time Frame: week 8
|
Hip Circumference will be measured for each participant
|
week 8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood Pressure
Time Frame: baseline
|
Blood pressure will be taken using an automatic blood pressure machine
|
baseline
|
|
Blood Pressure
Time Frame: week 4
|
Blood pressure will be taken using an automatic blood pressure machine
|
week 4
|
|
Blood Pressure
Time Frame: week 8
|
Blood pressure will be taken using an automatic blood pressure machine
|
week 8
|
|
Joint Pain
Time Frame: baseline
|
Joint pain will be assessed using The WOMAC (Western Ontario and McMaster Universities) Index of Osteoarthritis
|
baseline
|
|
Joint Pain
Time Frame: week 4
|
Joint pain will be assessed using The WOMAC (Western Ontario and McMaster Universities) Index of Osteoarthritis
|
week 4
|
|
Joint Pain
Time Frame: week 8
|
Joint pain will be assessed using The WOMAC (Western Ontario and McMaster Universities) Index of Osteoarthritis
|
week 8
|
|
Mood
Time Frame: Baseline
|
Major Depression Inventory
|
Baseline
|
|
Mood
Time Frame: week 4
|
Major Depression Inventory
|
week 4
|
|
Mood
Time Frame: week 8
|
Major Depression Inventory
|
week 8
|
|
Physical Activity
Time Frame: Baseline
|
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE (August 2002) SHORT LAST 7 DAYS SELF-ADMINISTERED FORMAT
|
Baseline
|
|
Physical Activity
Time Frame: week 4
|
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE (August 2002) SHORT LAST 7 DAYS SELF-ADMINISTERED FORMAT
|
week 4
|
|
Physical Activity
Time Frame: week 8
|
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE (August 2002) SHORT LAST 7 DAYS SELF-ADMINISTERED FORMAT
|
week 8
|
|
Sleep Quality
Time Frame: Baseline
|
Measuring sleep quality using the Pittsburgh Sleep Quality Index
|
Baseline
|
|
Sleep Quality
Time Frame: week 4
|
Measuring sleep quality using the Pittsburgh Sleep Quality Index
|
week 4
|
|
Sleep Quality
Time Frame: week 8
|
Measuring sleep quality using the Pittsburgh Sleep Quality Index
|
week 8
|
|
Fat mass
Time Frame: Baseline
|
using a tanita scale
|
Baseline
|
|
Fat mass
Time Frame: week 4
|
using a tanita scale
|
week 4
|
|
Fat mass
Time Frame: week 8
|
using a tanita scale
|
week 8
|
|
Fat Free Mass
Time Frame: Baseline
|
using a tanita scale
|
Baseline
|
|
Fat Free Mass
Time Frame: week 4
|
using a tanita scale
|
week 4
|
|
Fat Free Mass
Time Frame: week 8
|
using a tanita scale
|
week 8
|
|
Total body water
Time Frame: Baseline
|
using a tanita scale
|
Baseline
|
|
Total body water
Time Frame: week 4
|
using a tanita scale
|
week 4
|
|
Total body water
Time Frame: week 8
|
using a tanita scale
|
week 8
|
|
Macro nutrient intake
Time Frame: Baseline
|
3, 3-day diet journals will be collected using a paper method
|
Baseline
|
|
Macro nutrient intake
Time Frame: week 4
|
3, 3-day diet journals will be collected using a paper method
|
week 4
|
|
Macro nutrient intake
Time Frame: week 8
|
3, 3-day diet journals will be collected using a paper method
|
week 8
|
|
Micronutrient intake
Time Frame: Baseline
|
3, 3-day diet journals will be collected using a paper method
|
Baseline
|
|
Micronutrient intake
Time Frame: week 4
|
3, 3-day diet journals will be collected using a paper method
|
week 4
|
|
Micronutrient intake
Time Frame: week 8
|
3, 3-day diet journals will be collected using a paper method
|
week 8
|
|
Dietary intake Satiety
Time Frame: Baseline
|
3, 3-day diet journals will be collected using a paper method
|
Baseline
|
|
Dietary intake Satiety
Time Frame: week 4
|
3, 3-day diet journals will be collected using a paper method
|
week 4
|
|
Dietary intake Satiety
Time Frame: week 8
|
3, 3-day diet journals will be collected using a paper method
|
week 8
|
|
Dietary intake displacement
Time Frame: Baseline
|
3, 3-day diet journals will be collected using a paper method
|
Baseline
|
|
Dietary intake displacement
Time Frame: week 4
|
3, 3-day diet journals will be collected using a paper method
|
week 4
|
|
Dietary intake displacement
Time Frame: week 8
|
3, 3-day diet journals will be collected using a paper method
|
week 8
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Bonny Burns-Whitmore, DrPh, RD, California State Polytechnic University, Pomona
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 20, 2017
Primary Completion (Anticipated)
May 1, 2018
Study Completion (Anticipated)
August 1, 2018
Study Registration Dates
First Submitted
July 17, 2017
First Submitted That Met QC Criteria
July 27, 2017
First Posted (Actual)
July 31, 2017
Study Record Updates
Last Update Posted (Actual)
May 11, 2018
Last Update Submitted That Met QC Criteria
May 8, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-16-188
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Chia Seeds- Salvia Hispanica
-
Instituto Mexicano del Seguro SocialUnknownMetabolic Syndrome XMexico
-
Unity Health TorontoCompletedPost Prandial Blood GlucoseCanada
-
Mayo ClinicNational Cancer Institute (NCI)CompletedDiffuse Large B-Cell Lymphoma | Splenic Marginal Zone Lymphoma | Mantle Cell Lymphoma | Mycosis Fungoides | Sezary Syndrome | Lymphoplasmacytic Lymphoma | Anaplastic Large Cell Lymphoma | Blastic Plasmacytoid Dendritic Cell Neoplasm | Primary Effusion Lymphoma | Adult T-Cell Leukemia/Lymphoma | Post-Transplant... and other conditionsUnited States
-
University of OklahomaBrigham and Women's Hospital; Presbyterian Health FoundationNot yet recruitingBreastfeeding, Exclusive | Obesity and OverweightUnited States
-
Aimmune Therapeutics, Inc.RecruitingStress | Dietary Fiber | Stool Spore Colony Forming Units | Microbiome CompositionUnited States
-
Unity Health TorontoCanadian Diabetes AssociationCompletedObesity | Diabetes Mellitus | OverweightCanada
-
USDA Beltsville Human Nutrition Research CenterCompleted
-
University of ChicagoNot yet recruitingBreast CancerUnited States
-
USDA Beltsville Human Nutrition Research CenterActive, not recruiting
-
Instituto Nacional de Cardiologia Ignacio ChavezCompletedDietary Modification | Non-Alcoholic Fatty Liver Disease